Intraocular lens implantation for infants with aphakia: a systematic review of clinical effectiveness and cost-effectiveness

Record ID 32018002266
Authors' objectives: CADTH is undertaking a project on intraocular lens (IOL) implantation for infants with aphakia. Aphakia is the absence of the lens of the eye, due to surgical removal, a perforating wound or ulcer, or congenital anomaly. Interventions for optical correction of aphakia in children include aphakic glasses or contact lenses and primary or secondary IOL implantation. However, the optimal timing of primary IOL implantation in pediatric aphakic patients is unclear and remains a challenge for ophthalmologists. Intraocular lens implantation for infants younger than 12 months old would reduce the need for compliance with the alternative external optical devices and associated ongoing costs for parents and caregivers; however, concerns about selecting the appropriate lens power and long-term effectiveness remain. This systematic review will address the effectiveness and safety of IOL implantation in infants younger than 12 months old. In addition, the economic literature will be reviewed to evaluate whether this intervention is cost-effective.
Project Status: Completed
Year Published: 2022
English language abstract: An English language summary is available
Publication Type: Mini HTA
Country: Canada
MeSH Terms
  • Aphakia
  • Infant
  • Child
  • Lens Implantation, Intraocular
  • Visual Acuity
  • Intraocular lens
  • Aphakia
  • Infant
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
Contact Email:
Copyright: <p>Canadian Agency for Drugs and Technologies in Health (CADTH)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.